Affiliation:
1. Department of Clinical Science, Faculty of Veterinary Medicine Razi University Kermanshah Iran
2. Department of Ophthalmology, Faculty of Medicine Kermanshah University of Medical Sciences Kermanshah Iran
Abstract
AbstractBackgroundThe ocular side effects of cancer chemotherapeutic drugs are relatively uncommon. Nonetheless, the ocular system has a potentially high sensitivity to toxic substances. This study proposed a framework to assess the effect of vincristine chemotherapy on intraocular pressure, tear protein, and oxidative stress in canines with transmissible venereal tumor (TVT).MethodsThe study group comprised 10 dogs with TVT, whose diagnosis was based on cytology, and all dogs were treated with vincristine for 4 weeks. Each animal was given a complete ophthalmic examination, followed by a standard Schirmer tear test. Before and 20 min after administering vincristine, intraocular pressure (IOP) was measured in the eyes with a noncontact tonometer. At any of the times mentioned, tear samples were collected using the Schirmer test procedure and were subjected to protein analysis—oxidative stress index (OSI), total antioxidant capacity (TAC), total oxidant status (TOS), nitric oxide (NO), and malondialdehyde (MDA) were determined, and standard statistical analysis was applied.ResultsNo significant differences were found in protein in tears, but mean Pre and Postinjection IOP revealed a significant decrease in the eyes each week. Also, results indicated significant differences in oxidative stress markers: increased OSI, NO, and MDA, and reduced TAC.ConclusionThe importance of an increase in oxidative stress levels in the tears of vincristine‐treated patients should be taken seriously, as it appears to play a role in the pathogenesis of eye disease. Therefore, during the treatment weeks prior to prescribing vincristine, eye diseases should be evaluated and considered.
Reference45 articles.
1. Ocular Complications of Systemic Medications
2. Ocular side effects of common systemic medications and systemic side effects of ocular medications;Syed MF;Med Clin,2021
3. Ocular Toxicities in Cancer Therapy: Still Overlooked
4. Vincristine: Beyond on anticancer treatment
5. Review on canine transmissible venereal tumor (CTVT);Abeka YT;Cancer Ther Oncol Int J,2019